FDA Approves New Treatment for Advanced Melanoma
MONDAY, Feb. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer. Amtagvi, made by Iovance Biotherapeutics Inc., becomes the first cellular therapy approved to treat this form of solid tumor cancer. “Unresectable, orContinue Reading